New insights into store-independent Ca 2+ entry: Secretory pathway calcium ATPase 2 in normal physiology and cancer

International Journal of Oral Science

Volumn 5, Issue 2, 2013, Pages 71-74

  Feng, Ming Ye ^a,b   Rao, Rajini ^b  

^a SICHUAN UNIVERSITY   (China)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ca2+ signaling; human cancers; store independent Ca2+ entry; store operated Ca2+ entry

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ATP2C2 PROTEIN, HUMAN; CALCIUM CHANNEL; ORAI1 PROTEIN, HUMAN;

CALCIUM SIGNALING; CELL PROLIFERATION; CELL TRANSFORMATION; HUMAN; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; REVIEW;

CALCIUM CHANNELS; CALCIUM SIGNALING; CALCIUM-TRANSPORTING ATPASES; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASMS; PROGNOSIS;

EID: 84881586002     PISSN: 16742818     EISSN: 20493169     Source Type: Journal    
DOI: 10.1038/ijos.2013.23     Document Type: Review

References (25)

1. Strehler EE, Zacharias DA. Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. Physiol Rev 2001; 81(1): 21-50.
2. East JM. Sarco(endo)plasmic reticulum calcium pumps: recent advances in our understanding of structure/function and biology (review). Mol Membr Biol 2000; 17(4): 189-200.
3. 21-ATPase in yeast Golgi, has properties distinct from sarco/endoplasmic reticulum and plasma membrane calcium pumps. J Biol Chem 1997; 272(15): 9895-9901.
4. 21 required for glycosylation, sorting, and endoplasmic reticulum-associated protein degradation. Mol Biol Cell 1998; 9(5): 1149-1162.
5. 21 ions. J Biol Chem 2005; 280(24): 22800-22808.
6. 21-ATPase, hSPCA2, has unusual properties and is expressed in the brain. J Biol Chem 2005; 280(12): 11608-11614.
7. 21-ATPase (SPCA1) in mice causes Golgi stress, apoptosis, and midgestational death in homozygous embryos and squamous cell tumors in adult heterozygotes. J Biol Chem 2007; 282(36): 26517-26527.
8. Feng M, Grice DM, Faddy HM et al. Store-independent activation of Orai1 by SPCA2 in mammary tumors. Cell 2010; 143(1): 84-98.
9. Parekh AB, Putney JW Jr. Store-operated calcium channels. Physiol Rev 2005; 85(2): 757-810.
10. Cahalan MD, Zhang SL, Yeromin AV et al. Molecular basis of the CRAC channel. Cell Calcium 2007; 42(2): 133-144.
11. 21 entry and NFAT activation in lymphocytes. Cell Calcium 2007; 42(2): 145-156.
12. Lewis RS. The molecular choreography of a store-operated calcium channel. Nature 2007; 446(7133): 284-287.
13. Vig M, Kinet JP. The long and arduous road to CRAC. Cell Calcium 2007; 42(2): 157-162.
14. Feske S, Gwack Y, Prakriya M et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 2006; 441(7090): 179-185.
15. Prakriya M, Feske S, Gwack Y et al. Orai1 is an essential pore subunit of the CRAC channel. Nature 2006; 443(7108): 230-233.
16. 21 entry. Science 2006; 312(5777): 1220-1223.
17. Garside VC, Kowalik AS, Johnson CL et al. MIST1 regulates the pancreatic acinar cell expression of Atp2c2, the gene encoding secretory pathway calcium ATPase 2. Exp Cell Res 2010; 316(17): 2859-2870.
18. Lee WJ, Monteith GR, Roberts-Thomson SJ. Calcium transport and signaling in the mammary gland: targets for breast cancer. Biochim Biophys Acta 2006; 1765(2): 235-255.
19. Faddy HM, Smart CE, Xu R et al. Localization of plasma membrane and secretory calcium pumps in the mammary gland. Biochem Biophys Res Commun 2008; 369(3): 977-981.
20. 21-ATPase type 2. Biochem Biophys Res Commun 2007; 352(2): 537-542.
21. Jiang L, Zeng X, Yang H et al. Oral cancer overexpressed 1 (ORAOV1): a regulator for the cell growth and tumor angiogenesis in oral squamous cell carcinoma. Int J Cancer 2008; 123(8): 1779-1786.
22. 21 pump. J Biol Chem 2001; 276(29): 26737-26740.
23. 21 ATPase type 2 downregulated in human oral squamous cell carcinoma. Int J Cancer 2004; 110(2): 225-231.
24. 21 ATPase isoform 1 down-regulated in human oral cancer. Oncol Rep 2006; 15(1): 49-55.
25. i increases and cell proliferation induced by the carcinogen safrole in human oral cancer cells. Naunyn Schmiedebergs Arch Pharmacol 2005; 372(1): 88-94.